A new research suggests that fenofibrate, a common drug used to control cholesterol levels in patients, activates the same receptors as cannabis and may become a viable treatment option for relieving pain, stimulating appetite, reducing nausea and preventing depression.
These are the benefits of medical marijuana without the "unwanted side effects" of cannabis. "By illustrating the relationship between fenofibrate and the cannabinoid system, we aim to improve our understanding of this clinically important drug," said Dr. Richard S. Priestley from the University of Nottingham, England.
New Cannabis Users in Spain Outnumber New Tobacco Users
The number of people in Spain who said they started using cannabis in 2013 outnumbered those who said they took up smoking cigarettes.
Advertisement
According to the research report published in the FASEB Journal, fenofibrate may benefit a wide range of health issues, such as appetite stimulation, pain and nausea control, as well as immune and various psychiatric and neurological conditions. This suggests that fenofibrate may be the starting point for a new class of cannabis-like drugs to treat these types of conditions.
"Our study provides the basis for the investigation of new drugs targeting these important receptors," Priestley said.
To make this discovery, Priestly and colleagues cultured cells containing cannabinoid receptors and exposed them to a tracer compound, which binds to cannabinoid receptors. They found that fenofibrate was able to displace the tracer, suggesting that it also binds to the receptors.
![Therapeutic Role of Medical Cannabis to be Explored]( "Therapeutic Role of Medical Cannabis to be Explored")
Cannabis is a dried preparation of the cannabis plant used as a psychotropic drug, mainly in cigarettes.
Furthermore, they discovered that fenofibrate actually switched the cannabinoid receptors "on", not only in these cells, but also in sections of intestine. This led to the relaxation of the tissue in a way that mimicked what marijuana does.
Despite the fact that fenofibrate has been used for many years, and its mechanism of action was presumed to be through a completely different family of receptors, this suggests that at least some of the effects of fenofibrate may be controlled by cannabinoid receptors.
Furthermore, these cannabinoid receptors may be a future target for drugs used to treat pain and a variety of immune and psychiatric diseases.
Source: IANS
To make this discovery, Priestly and colleagues cultured cells containing cannabinoid receptors and exposed them to a tracer compound, which binds to cannabinoid receptors. They found that fenofibrate was able to displace the tracer, suggesting that it also binds to the receptors.
Therapeutic Role of Medical Cannabis to be Explored
Cannabis is a dried preparation of the cannabis plant used as a psychotropic drug, mainly in cigarettes.
Advertisement
Furthermore, they discovered that fenofibrate actually switched the cannabinoid receptors "on", not only in these cells, but also in sections of intestine. This led to the relaxation of the tissue in a way that mimicked what marijuana does.
Despite the fact that fenofibrate has been used for many years, and its mechanism of action was presumed to be through a completely different family of receptors, this suggests that at least some of the effects of fenofibrate may be controlled by cannabinoid receptors.
Furthermore, these cannabinoid receptors may be a future target for drugs used to treat pain and a variety of immune and psychiatric diseases.
Source: IANS
New Uruguay Government in 'No Rush' to Sell Cannabis at Pharmacies
The newly sworn-in Uruguayan President Tabare Vazquez's government is in no hurry to implement his predecessor's controversial world-first law allowing marijuana sales at pharmacies.
Advertisement
 Growth of Brain Cancer Tumors may be Slowed Down by Cannabis ExtractsCannabis extracts can help slow the growth of cancerous tumors when used alongside radiotherapy treatments, says a new study. | Advertisement
|
Advertisement
Recommended Reading
Latest Drug News
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial